Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera, FT reports

(Reuters) -Pfizer is closing in on a potential $7.3 billion takeover of anti-obesity drug developer Metsera, the Financial Times reported on Sunday, citing unidentified sources.

Pfizer will pay Metsera $47.50 in cash per share and a further $22.50 if certain performance milestones are met, the newspaper said, adding that the announcement could come as early as Monday.

Reuters could not immediately confirm the report.

Metsera and Pfizer did not immediately respond to a Reuters request for comment outside regular business hours.

(Reporting by Mrinmay Dey in Bengaluru; Editing by Janane Venkatraman)